Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.

BMC Neurol · 2020 · PMC7052969 · PMID 32126977

Europe PMC DOI

hedged sentence

0.1220

closest p · 2.4× alpha

0.1220

boldest claim

The sentences

an apparent trendp = 0.122not close (p > 0.1)

An apparent trend for improved visual quality of life with fingolimod treatment did not meet statistical significance (interaction treatment arm*time: p = 0.122; Supplementary Figure S5 ).

also in 709 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.